Thursday, March 02, 2017 10:24:13 AM
1. I am a former institutional investor, and remember having lunch one day in Bejing with Robert Friedland. He is a smart fellow, but also too much of a showman, MS is more technical and I prefer his style. They both run the only viable scandium projects out there, and RF will do a great job of introducing Scandium to institutions along with Mark. Their success will help Niocorp succeed as well.
2. The recent purchase of 16.5 percent of Cleanteq by a Chinese conglomerate does several positive things. It gives some proof of concept to a scandium project that is paired with other products. Cobalt for Cleanteq and Niobium for Niocorp.
3. With the newly announced investment in Cleanteq by a Chinese conglomerate, they will most likely lock up the scandium and cobalt produced for Chinese benefit. They will also help to develop even more uses.
4. This really just leaves Niocorp, large investors and the US government knows this.
5. Trying to predict prices of Scandium is a fools game. One could make assumptions, but the variability of demand going forward (the timing of the uptake) will be bumpy. Ordinarily this would mean financing would have to have a larger equity componant, but Niobium pricing is extraordinarily stable and the German government can provide a certain level of debt financing which can be subordinated thereby lowering the overall cost of capital.
6. There are other positives, there are other uncertainties. On balance for me, these positives announced make the project worthy of investment. Size to your risk tolerance and hold for the longterm.
Recent NB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 04:28:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:02:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:01:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:01:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:00:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:00:27 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 12/21/2023 09:45:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:55:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 12:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 09:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 12:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:30:22 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM